Loss of KAI1 messenger RNA expression in both high-grade and invasive human bladder cancers

Clinical Cancer Research

Volumn 3, Issue 7, 1997, Pages 1045-1049

  Yu, Yan ^a   Yang, Jia Lin ^a   Markovic, Boban ^b   Jackson, Paul ^a   Yardley, Gina ^a   Barrett, Julie ^a   Russell, Pamela J ^a  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ARTICLE; BLADDER CARCINOGENESIS; BLADDER CARCINOMA; CHROMOSOME 11P; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; METASTASIS POTENTIAL; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANTIGENS, CD; CARCINOMA, TRANSITIONAL CELL; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 11; HUMANS; KANGAI-1 PROTEIN; MALE; MEMBRANE GLYCOPROTEINS; NEOPLASM INVASIVENESS; PROSTATE; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; REFERENCE VALUES; RNA, MESSENGER; TRANSCRIPTION, GENETIC; URINARY BLADDER NEOPLASMS;

EID: 0030878411     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Boring, C. C., Squires, T. S., and Tong, T. Cancer statistics, 1993. CA Cancer J. Clin., 43: 7-26, 1993.
2. Silverberg, E., Boring, C. C., and Squires, T. Cancer statistics, 1990. CA Cancer J. Clin., 40: 9-26, 1990.
3. Coates, M., McClerdie, M., and Taylor, R. Cancer in New South Wales: incidence and mortality 1991. NSW Cancer Council Rep., 56-57, 1994.
4. Lerner, S. P., Skinner, E., and Skinner, D. G. Radical cystectomy in regionally advanced bladder cancer. Urol. Clin. North Am., 19: 713-723, 1992.
5. Jordan, A. M., Weingarten, J., and Murphy, W. A. Transitional cell neoplasms of the urinary bladder: can biologic behavior be predicted from histologic grading? Cancer (Phila.). 60: 2766-2774, 1987.
6. Kroft, S. H., and Oyasu, R. Urinary bladder cancer: mechanisms of development and progression. Lab. Invest., 71: 158-174, 1994.
7. Raghavan, D., and Huben, R. Management of bladder cancer. Current Probl. Cancer, 19: 4-63, 1995.
8. Spruck, C. H., III, Ohneseit, P. F., Gonzalez-Zulueta, M., Esrig, D., Miyao, N., Tsai, Y. C., Hermann, G. G., Steven, K., Horn, T., Skinner, D. G., and Jones, P. A. Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res., 54: 784-788, 1994.
9. Reznikoff, C. A., Kao, C., Messing, E. M., Newton, M., and Swaminathan, S. A molecular genetic model of human bladder carcinogenesis. Semin. Cancer Biol., 4: 143-152, 1993.
10. Voorter, C. E., Ummelen, M. I., Ramaekers, F. S., and Hopman, A. H. Loss of chromosome 11 and 11 p/q imbalances in bladder cancer detected by fluorescence in situ hybridization. Int. J. Cancer, 65: 301-307, 1996.
11. Babu, V. R., Lutz, M. D., Miles, B. J., Farah, R. N., Weiss, L., and Van Dyke, D. L. Tumor behavior in transitional cell carcinoma of the bladder in relation to chromosomal markers and histopathology. Cancer Res., 47: 6800-6805, 1987.
12. Dong, J-T., Lamb, W. P., Rinker-Schaeffer, C. W., Vukanovic, J., Ichikawa, T., Isaacs, J. T., and Barrett, J. C. KAI 1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science (Washington DC). 268: 884-886, 1995.
13. Hemler, M. E., Mannion, B. A., and Berditchevski, F. Association of TM4SF proteins with integrins: relevance to cancer. Biochim. Biophys. Acta, 1287: 67-71, 1996.
14. Horejsi, V., and Vlcek, C. Novel structurally distinct family of leucocyte surface glycoproteins including CD9, CD37, CD53 and CD63. FEBS Lett., 288: 1-4, 1991.
15. Imai, T., Fukudome, K., Takagi, S., Nagira, M., Furuse, M., Fukuhara, N., Nishimura, M., Hinuma, Y., and Yoshie, O. C33 antigen recognized by monoclonal antibodies inhibitory to human T-cell leukemia virus type 1-induced syncytium formation is a member of a new family of transmembrane proteins including CD9, CD37, CD53, and CD63. J. Immunol., 149: 2879-2886, 1992.
16. Dong, J. T., Suzuki, H., Pin, S. S., Bova, G. S., Schalken, J. A., Isaacs, W. B., Barrett, J. C., and Isaacs, J. T. Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss. Cancer Res., 56: 4387-4390, 1996.
17. Wei, L. L., Yang, X., Phillips, K., Weissman, B. E., and Welch, D. R. Analysis of KAI1 mRNA expression in human breast cancer cell lines. Proc. Am. Assoc. Cancer Res., 37: A76, 1996.
18. Phillips, K., White, A. E., Barrett, J. C., Welch, D. R., and Weissman, B. E. Suppression of metastasis in the MDA-MB-435 breast carcinoma cell line after introduction of human chromosome 11 correlates with increased expression of KAI1 protein. Proc. Am. Assoc. Cancer Res., 37: 81, 1996.
19. Adachi, M., Taki, T., Leki, Y., Huang, C-L., Higashiyama, M., and Miyake, M. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer. Cancer Res., 56: 1751-1755, 1996.
20. Guo, X., Friess, H., Graber, H. U., Kashiwagi, M., Zimmermann, A., Korc, M., and Buchler, M. W. KAI1 expression is up-regulated in early pancreatic cancer and decreases in the presence of metastases. Cancer Res., 56: 4876-4880, 1996.
21. Russell, P. J., Raghavan, D., Philips, J., and Wills, E. J. The biology of urothelial cancer. In: D. Raghavan (ed.), The Management of Bladder Cancer, pp. 1-3. Sevenoaks, England: Edward Arnold, Ltd., 1988.
22. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual, Ed. 2, Vol. 6, pp. 31-32. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
23. Markovic, B., Wu, Z. H., Chesterman, C. N., and Chong, B. H. Quantitation of Fc γ RII mRNA in platelets and megakaryoblastic cell lines by a new method of in situ hybridization. J. Immunol. Methods, 172: 105-114, 1994.
24. Erba, H. P., Gunning, P., and Kedes, L. Nucleotide sequence of the human γ cytoskeletal actin mRNA; anomalous evolution of vertebrate non-muscle actin genes. Nucleic Acids Res., 14: 5275-5294, 1986.
25. Forster, A. C., McInnes, J. L., Skingle, D. C., and Symons, R. H. Non-radioactive hybridization of probes prepared by the chemical labeling of DNA and RNA with a novel reagent, photobiotin. Nucleic-Acids Res., 13: 745-761, 1985.
26. Hopman, A. H. N., Moesker, O., Wim, A., Smeets, G. B., Pauwels, R. P. E., Voojis, G. P., and Ramaekers, F. C. S. Numerical chromosome 1,7,9, and 11 aberrations in bladder cancer detected by in situ hybridization. Cancer Res., 51: 644-651, 1991.
27. Waldman, F. M., Carroll, P. R., Kerschmann, R., Cohen, M. B., Field, F. G., and Mayall, B. H. Centromeric copy number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer. Cancer Res., 51: 3807-3813, 1991.
28. Berditchevski, F., Tolias, K. F., Wong, K., Carpenter, R. C. L., and Hemler, M. E. A novel link between integrins, transmembrane-4 superfamily proteins (CD63 and CD81) and phosphatidylinositol 4-kinase. J. Biol. Chem., 272: 2595-2598, 1997.